![]() |
Name |
(7S)-7-benzyl-4-butan-2-yl-15-oxa-2,5,8-triazatricyclo[8.5.0.03,8]pentadeca-1(10),2,11,13-tetraene-6,9-dione
|
Molecular Formula | C22H23N3O3 | |
IUPAC Name* |
(7S)-7-benzyl-4-butan-2-yl-15-oxa-2,5,8-triazatricyclo[8.5.0.03,8]pentadeca-1(10),2,11,13-tetraene-6,9-dione
|
|
SMILES |
CCC(C)C1C2=NC3=C(C=CC=CO3)C(=O)N2[C@H](C(=O)N1)CC4=CC=CC=C4
|
|
InChI |
InChI=1S/C22H23N3O3/c1-3-14(2)18-19-24-21-16(11-7-8-12-28-21)22(27)25(19)17(20(26)23-18)13-15-9-5-4-6-10-15/h4-12,14,17-18H,3,13H2,1-2H3,(H,23,26)/t14?,17-,18?/m0/s1
|
|
InChIKey |
UOBOWSHNMYJJFQ-GMXGEUMGSA-N
|
|
Synonyms |
Brevianamide P
|
|
CAS | NA | |
PubChem CID | 102054512 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 377.4 | ALogp: | 3.4 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 71.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 28 | QED Weighted: | 0.876 |
Caco-2 Permeability: | -4.744 | MDCK Permeability: | 0.00003170 |
Pgp-inhibitor: | 0.968 | Pgp-substrate: | 0.008 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.032 | Plasma Protein Binding (PPB): | 98.10% |
Volume Distribution (VD): | 0.373 | Fu: | 0.80% |
CYP1A2-inhibitor: | 0.854 | CYP1A2-substrate: | 0.308 |
CYP2C19-inhibitor: | 0.607 | CYP2C19-substrate: | 0.314 |
CYP2C9-inhibitor: | 0.893 | CYP2C9-substrate: | 0.754 |
CYP2D6-inhibitor: | 0.089 | CYP2D6-substrate: | 0.288 |
CYP3A4-inhibitor: | 0.617 | CYP3A4-substrate: | 0.754 |
Clearance (CL): | 6.329 | Half-life (T1/2): | 0.728 |
hERG Blockers: | 0.054 | Human Hepatotoxicity (H-HT): | 0.549 |
Drug-inuced Liver Injury (DILI): | 0.171 | AMES Toxicity: | 0.027 |
Rat Oral Acute Toxicity: | 0.165 | Maximum Recommended Daily Dose: | 0.987 |
Skin Sensitization: | 0.055 | Carcinogencity: | 0.964 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.014 |
Respiratory Toxicity: | 0.351 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004267 | ![]() |
0.670 | D0J6WW | ![]() |
0.287 | ||
ENC004609 | ![]() |
0.545 | D0O7SP | ![]() |
0.285 | ||
ENC003272 | ![]() |
0.490 | D0QV5T | ![]() |
0.284 | ||
ENC004348 | ![]() |
0.459 | D05EPM | ![]() |
0.284 | ||
ENC004646 | ![]() |
0.440 | D06ZPS | ![]() |
0.276 | ||
ENC004647 | ![]() |
0.440 | D0R2OA | ![]() |
0.273 | ||
ENC004606 | ![]() |
0.440 | D07VHR | ![]() |
0.270 | ||
ENC004605 | ![]() |
0.440 | D0T5UL | ![]() |
0.269 | ||
ENC004645 | ![]() |
0.425 | D09NNH | ![]() |
0.268 | ||
ENC004608 | ![]() |
0.420 | D07RGW | ![]() |
0.265 |